Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8

被引:118
作者
Shin, S
Lee, Y
Kim, W
Ko, H
Choi, H
Kim, K
机构
[1] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Brain Korea Project Med Sci 21, Seoul 120752, South Korea
[2] Nanomed Natl Core Res Ctr, Pohang, South Korea
[3] PNI Inc Ltd, Pohang, South Korea
关键词
caspase-2; caspase-8; PKCK2; priming; TRAIL;
D O I
10.1038/sj.emboj.7600827
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although caspase-2 is believed to be involved in death receptor-mediated apoptosis, the exact function, mode of activation, and regulation of caspase-2 remain unknown. Here we show that protein kinase (PK) CK2 phosphorylates procaspase-2 directly at serine-157. When intracellular PKCK2 activity is low or downregulated by specific inhibitors, procaspase-2 is dephosphorylated, dimerized, and activated in a PIDDosome-independent manner. The activated caspase-2 then processes procaspase-8 monomers between the large and small subunits, thereby priming cancer cells for TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis. The processed procaspase-8 that is recruited to death-inducing signaling complex by TRAIL engagement becomes fully activated, and cancer cells undergo apoptosis. PKCK2 activity is low in TRAIL-sensitive cancer cell lines but high in TRAIL-resistant cancer cell lines. Thus, downregulating PKCK2 activity is required for TRAIL-mediated apoptosis to occur in TRAIL-resistant cancer cells. Our data provide novel insights into the regulation, mode of activation, and function of caspase-2 in TRAIL-mediated apoptosis.
引用
收藏
页码:3532 / 3542
页数:11
相关论文
共 39 条
[1]  
Ahmed K, 2000, J CELL BIOCHEM, P130
[2]   PROTEIN KINASES .4. PROTEIN-KINASE CK2 - AN ENZYME WITH MULTIPLE SUBSTRATES AND A PUZZLING REGULATION [J].
ALLENDE, JE ;
ALLENDE, CC .
FASEB JOURNAL, 1995, 9 (05) :313-323
[3]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[4]   Defects in regulation of apoptosis in caspase-2-deficient mice [J].
Bergeron, L ;
Perez, GI ;
Macdonald, G ;
Shi, LF ;
Sun, Y ;
Jurisicova, A ;
Varmuza, S ;
Latham, KE ;
Flaws, JA ;
Salter, JCM ;
Hara, H ;
Moskowitz, MA ;
Li, E ;
Greenberg, A ;
Tilly, JL ;
Yuan, JY .
GENES & DEVELOPMENT, 1998, 12 (09) :1304-1314
[5]   A unified model for apical caspase activation [J].
Boatright, KM ;
Renatus, M ;
Scott, FL ;
Sperandio, S ;
Shin, H ;
Pedersen, IM ;
Ricci, JE ;
Edris, WA ;
Sutherlin, DP ;
Green, DR ;
Salvesen, GS .
MOLECULAR CELL, 2003, 11 (02) :529-541
[6]   Interdimer processing mechanism of procaspase-8 activation [J].
Chang, DW ;
Xing, Z ;
Capacio, VL ;
Peter, ME ;
Yang, XL .
EMBO JOURNAL, 2003, 22 (16) :4132-4142
[7]   Activation of initiator caspases through a stable dimeric intermediate [J].
Chen, M ;
Orozco, A ;
Spencer, DM ;
Wang, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (52) :50761-50767
[8]   Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells [J].
Droin, N ;
Bichat, F ;
Rébé, C ;
Wotawa, A ;
Sordet, O ;
Hammann, A ;
Bertrand, R ;
Solary, E .
BLOOD, 2001, 97 (06) :1835-1844
[9]   RAIDD is a new 'death' adaptor molecule [J].
Duan, H ;
Dixit, VM .
NATURE, 1997, 385 (6611) :86-89
[10]   Elevated protein kinase CK2 activity in chromatin of head and neck tumors: Association with malignant transformation [J].
Faust, RA ;
Gapany, M ;
Tristani, P ;
Davis, A ;
Adams, GL ;
Ahmed, K .
CANCER LETTERS, 1996, 101 (01) :31-35